Commodities snapshot: gold near $4,450/oz, silver above $70/oz, copper at record highs. Oil slipped by a few tenths of a percent. These moves reflect tight physical markets and shifting investor demand into year end. #Gold #Oil #Silver #FiatNews

Copper surged past $12,000 per tonne to a record high, driven by significant mining outages and disruptions to trade flows linked to US tariff policy, pushing the metal to new highs. #Copper #FiatNews

Investor Steve Eisman said markets are now driven less by Fed rate decisions and more by the prospects for AI; he described the Fed’s current role as fine-tuning policy rather than setting market direction. #AI #Fed #FiatNews

Bloomberg Intelligence expects European industrial profits to grow next year at about twice the rate of this year, citing easing tariff uncertainty, an AI infrastructure investment boom and rising demand for electrification. #Europe #Industry #FiatNews

Czech economic sentiment slipped in December: confidence among businesses and consumers fell 1.7 points to 100.2, remaining just above the long-term average, according to the Czech Statistical Office. #Czech #Confidence #FiatNews

The yen strengthened after the BoJ’s recent rate rise lacked a clear signal for further hikes; verbal intervention from Finance Minister Katayama — warning the government may act if currency moves stray from fundamentals — helped stabilize the yen. Analysts note a pain threshold near 160 vs. USD. #USDJPY #FiatNews

European equities traded positively ahead of the holidays; the STOXX 600 gained almost 0.5% as investors closed positions for year end. Several stocks saw notable gains on company-specific news. #Stoxx600 #Europe #FiatNews

Silver topped $70 per troy ounce for the first time in history, while gold approached $4,450/oz. Both metals hit record territory amid broad commodity strength. #Silver #Gold #FiatNews

Intel posted a busy 2025: leadership changes and large investments from the US government, Nvidia and SoftBank. Shares rose by tens of percent over the year, but the company’s foundry business has not yet recovered. #Intel #FiatNews

Novo Nordisk won US approval to sell a pill form of its obesity drug Wegovy. The approval is seen as a key step to defend market share against Eli Lilly; the company's shares jumped nearly 10% on the news. #NovoNordisk #Wegovy #FiatNews

US GDP growth accelerated unexpectedly to an annualized 4.3% in the third quarter, up from 3.8% in Q2. Economists had forecast a slowdown to 3.3%. The release was delayed due to a temporary federal shutdown that limited government operations, influencing the timing of the data. #GDP #USAEconomy #FiatNews

U.S. economic growth accelerated unexpectedly in the third quarter, with real gross domestic product rising at an annualized rate of 4.3% versus 3.8% in the second quarter, according to data released December 23, 2025. The increase was larger than many forecasts, marking a notable pickup in activity for Q3. The figure is expressed in annualized terms, showing the quarter’s pace extrapolated over a year. The report highlights a faster-than-expected expansion compared with the prior quarter’s 3.8% annualized gain. Officials and market participants will use the outturn as a key input for assessing near-term demand and policy decisions, though the release provides a snapshot for Q3 only. #USGDP #economy #GDP #FiatNews

Intel closed out a busy 2025 with its shares rising by tens of percent, but a hoped-for turnaround in its foundry business has not yet materialized. Despite market gains, the company has not yet shown a clear revival in contract-manufacturing activity. #INTC #semiconductors The year brought major developments: a new chief executive took the helm and Intel attracted multibillion-dollar commitments from the U.S. government as well as strategic investments from Nvidia and SoftBank. Those moves supported investor sentiment and contributed to the strong share performance. The injections of capital and leadership change were presented as steps to strengthen Intel’s manufacturing capabilities and better position it against rivals, but operational progress in the foundry segment remains limited so far. Continued attention will focus on whether planned investments translate into measurable growth in foundry customers and output. #NVDA #SoftBank #FiatNews

Bloomberg Intelligence says industrial profits in Europe are set to grow in 2026 at roughly twice the pace recorded in 2025. After a turbulent 2025, the report finds unusually strong optimism across the region’s industrial sector. Easing tariff uncertainty, a continuing investment boom into AI infrastructure and accelerating demand for electrification are cited as the main drivers creating an environment for faster earnings growth. Bloomberg Intelligence notes these factors could deliver the fastest profit growth for European industrial companies in several years. #BloombergIntelligence #Europe #Industry #AI #FiatNews

Confidence in the Czech economy eased in December, falling 1.7 points month‑on‑month to 100.2, the Czech Statistical Office (ČSÚ) reported on 23 December 2025. The decline appeared across both entrepreneurs and consumers, though the overall reading remained just above the long‑term average. The drop to 100.2 reflects a modest pullback in sentiment from November; the ČSÚ data show decreases in both business confidence and consumer confidence components. The index level, while lower, still hovers slightly above its historical norm. Data were published by the Czech Statistical Office on 23 December 2025. #CzechRepublic #economy #ČSÚ #consumerconfidence #FiatNews

23 Dec 2025 — European equities traded mixed with small moves on major indexes as holiday-thinned liquidity weighed. Solid performance on Wall Street the previous day failed to produce a full follow-through in Asia or Europe, leaving major bourses largely rangebound. #EuropeanStocks #FiatNews

23 Dec 2025 — Japan’s market moves were limited and responded mainly to verbal interventions by authorities rather than sustained trading flows. Local equities showed only short-lived reactions to commentary, while broader Asian markets did not mirror Wall Street’s prior strength. #Japan #FiatNews

23 Dec 2025 — Novo Nordisk shares rose after regulatory approval of a drug, making the company one of the day's stronger single-stock performers. The advance occurred as investors traded cautiously ahead of the holidays amid generally modest market activity across Europe. #NovoNordisk #FiatNews

On Dec. 23, 2025 the U.S. third-quarter GDP figure — the last major macro release postponed by the recent government shutdown — is scheduled for publication, with attention focused on whether annualized growth approached 4%. The question of a near-4% pace has been a central talking point ahead of today’s release. This data point was the final delayed number from the period of federal agency closures and will provide a complete picture of economic activity in Q3. Early estimates and commentary have emphasized the annualized rate as the key headline. The quarter’s GDP print is a primary gauge of overall economic momentum and will be closely examined by analysts and investors assessing recent growth dynamics. #USGDP #GDP #Q3 #macroeconomics #FiatNews

Novo Nordisk has won U.S. approval to market a tablet version of its obesity drug Wegovy, a move Bloomberg says is key to defending the company’s market share against rival Eli Lilly. The authorization, reported on Dec. 23, 2025, allows Novo Nordisk to offer an oral formulation of the medicine in the U.S. market. The approval represents a strategic step to broaden patient access and compete more directly with emerging alternatives from Eli Lilly. Wegovy is already established as a treatment for obesity; the tablet launch could affect prescribing patterns and market dynamics in the sector. Bloomberg is the source of the report; no additional sales forecasts or regulatory conditions were cited in the item. #NovoNordisk #Wegovy #EliLilly #obesity #FiatNews